Komori
Hochiki (6745) · FactUpdate to full-year research and development expenses

Research and Development Expenses of ¥1,777 million

First written in FY2017-Q3. 1 of 34 entries say "Advanced", first in FY2017. Latest entry: FY2026.

34entries
10years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q1 – FY20262017: 420172018: 420182019: 420192020: 420202021: 320212022: 420222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 204 companies write about · 0 as a headwind · 217 as a tailwind

90 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 219 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Update to full-year research and development expensesAnnual report

    「R&D expenses for the consolidated fiscal year amounted to ¥3,788 million.」

    Full-year R&D expenses amounted to ¥3,788 million, up from ¥3,523 million in the previous fiscal year.
  2. 2026-05-13OtherEarnings presentation

    「Research and development expenses 3,523 3,788 264 7.5%」

    The amended supplementary presentation materials disclosed research and development expenses of ¥3,523 million for the fiscal year ended March 2025 and ¥3,788 million for the fiscal year ended March 2026, up 7.5% year on year.
  3. FY2026-H1Interim R&D Expense UpdateAnnual report

    「Total R&D expenses for the interim consolidated accounting period amounted to ¥1,823 million.」

    R&D expenses for the interim consolidated accounting period are disclosed as ¥1,823 million.
  4. FY2025Update to full-year research and development expensesAnnual report

    「R&D expenses for the consolidated fiscal year amounted to ¥3,523 million.」

    Full-year R&D expenses amounted to ¥3,523 million, up from ¥3,166 million in the previous fiscal year.
  5. FY2025-H1Interim R&D Expense UpdateAnnual report

    「Total R&D expenses for the interim consolidated accounting period amounted to ¥1,705 million.」

    R&D expenses for the interim consolidated accounting period are disclosed as ¥1,705 million.
  6. FY2024Update to full-year research and development expensesAnnual report

    「R&D expenses for the consolidated fiscal year amounted to ¥3,166 million.」

    Full-year R&D expenses are disclosed as ¥3,166 million.
  7. FY2024-Q3Update to R&D expenses for the first 3 quartersAnnual report

    「Total R&D expenses for the cumulative consolidated third quarter amounted to ¥2,327 million.」

    R&D expenses for the cumulative consolidated third quarter are disclosed as ¥2,327 million.
  8. FY2024-Q2Semiannual R&D expense updateAnnual report

    「Total R&D expenses for the cumulative consolidated second quarter amounted to ¥1,484 million.」

    R&D expenses for the cumulative consolidated second quarter are disclosed as ¥1,484 million.
  9. FY2024-Q1First-quarter R&D expenses updatedAnnual report

    「Total R&D expenses for the cumulative consolidated first quarter amounted to ¥773 million.」

    R&D expenses for the cumulative consolidated first quarter are disclosed as ¥773 million.
  10. FY2023Update to full-year research and development expensesAnnual report

    「R&D expenses for the consolidated fiscal year amounted to ¥2,935 million.」

    Full-year R&D expenses are disclosed as ¥2,935 million.
  11. FY2023-Q3Update to R&D expenses for the first 3 quartersAnnual report

    「Total R&D expenses for the cumulative consolidated third quarter amounted to ¥2,174 million.」

    R&D expenses for the cumulative consolidated third quarter are disclosed as ¥2,174 million.
  12. FY2023-Q2Semiannual R&D expense updateAnnual report

    「Total R&D expenses for the cumulative consolidated second quarter amounted to ¥1,388 million.」

    R&D expenses for the cumulative consolidated second quarter are disclosed as ¥1,388 million.
  13. FY2023-Q1Update to quarterly R&D expensesAnnual report

    「Total R&D expenses for the cumulative consolidated first quarter amounted to ¥669 million.」

    R&D expenses for the cumulative consolidated first quarter are stated as ¥669 million.
  14. FY2022Update to full-year research and development expensesAnnual report

    「R&D expenses for the consolidated fiscal year amounted to ¥2,718 million.」

    Full-year R&D expenses are disclosed as ¥2,718 million.
  15. FY2022-Q3Update to quarterly R&D expensesAnnual report

    「Total R&D expenses for the cumulative consolidated third quarter amounted to ¥1,956 million.」

    R&D expenses for the cumulative consolidated third quarter are stated as ¥1,956 million.
  16. FY2022-Q2Semiannual R&D expense updateAnnual report

    「Total R&D expenses for the cumulative consolidated second quarter amounted to ¥1,250 million.」

    R&D expenses are stated as ¥1,250 million for the cumulative consolidated second quarter.
  17. FY2022-Q1Update to quarterly R&D expensesAnnual report

    「Total R&D expenses for the cumulative consolidated first quarter amounted to ¥601 million.」

    R&D expenses for the cumulative consolidated first quarter are stated as ¥601 million.
  18. FY2021-Q3Update to quarterly R&D expensesAnnual report

    「Total R&D expenses for the cumulative consolidated third quarter amounted to ¥1,976 million.」

    R&D expenses are stated as ¥1,976 million for the cumulative consolidated third quarter.
  19. FY2021-Q2Semiannual R&D expense updateAnnual report

    「Total R&D expenses for the cumulative consolidated second quarter amounted to ¥1,316 million.」

    R&D expenses are stated as ¥1,316 million for the cumulative consolidated second quarter.
  20. FY2021-Q1Update to quarterly R&D expensesAnnual report

    「Total R&D expenses for the cumulative consolidated first quarter amounted to ¥642 million.」

    R&D expenses are stated as ¥642 million for the current cumulative consolidated first quarter.
  21. FY2020Update to full-year research and development expensesAnnual report

    「R&D expenses for the consolidated fiscal year amounted to ¥2,649 million.」

    R&D expenses are stated as ¥2,649 million for the full year.
  22. FY2020-Q3Update to quarterly R&D expensesAnnual report

    「Total R&D expenses for the cumulative consolidated third quarter amounted to ¥1,895 million.」

    R&D expenses are stated as ¥1,895 million for the current cumulative consolidated third quarter.
  23. FY2020-Q2Semiannual R&D expense updateAnnual report

    「Total R&D expenses for the cumulative consolidated second quarter amounted to ¥1,253 million.」

    R&D expenses are stated as ¥1,253 million for the current cumulative consolidated second quarter.
  24. FY2020-Q1First-quarter R&D expenses updatedAnnual report

    「Total R&D expenses for the cumulative consolidated first quarter amounted to ¥601 million.」

    R&D expenses are stated as ¥601 million for the current cumulative consolidated first quarter.
  25. FY2019Update to full-year research and development expensesAnnual report

    「R&D expenses for the consolidated fiscal year amounted to ¥2,620 million.」

    R&D expenses are stated as ¥2,620 million for the full year.
  26. FY2019-Q3Update to quarterly R&D expensesAnnual report

    「Total R&D expenses for the cumulative consolidated third quarter amounted to ¥1,961 million.」

    R&D expenses are stated as ¥1,961 million for the cumulative consolidated third quarter.
  27. FY2019-Q2Semiannual R&D expense updateAnnual report

    「Total R&D expenses for the cumulative consolidated second quarter amounted to ¥1,325 million.」

    R&D expenses are stated as ¥1,325 million for the cumulative consolidated second quarter.
  28. FY2019-Q1First-quarter R&D expenses updatedAnnual report

    「Total R&D expenses for the cumulative consolidated first quarter amounted to ¥682 million.」

    R&D expenses are stated as ¥682 million for the current cumulative consolidated first quarter.
  29. FY2018Update to full-year research and development expensesAnnual report

    「R&D expenses for the consolidated fiscal year amounted to ¥2,721 million.」

    R&D expenses are stated as ¥2,721 million for the full year.
  30. FY2018-Q3Update to quarterly R&D expensesAnnual report

    「Total R&D expenses for the cumulative consolidated third quarter amounted to ¥1,979 million.」

    R&D expenses are stated as ¥1,979 million for the cumulative consolidated third quarter.
  31. FY2018-Q2Semiannual R&D expense updateAnnual report

    「Total R&D expenses for the cumulative consolidated second quarter amounted to ¥1,265 million.」

    R&D expenses are stated as ¥1,265 million for the cumulative consolidated second quarter.
  32. FY2018-Q1Update to quarterly R&D expensesAnnual report

    「Total R&D expenses for the cumulative consolidated first quarter amounted to ¥623 million.」

    R&D expenses are stated as ¥623 million for the cumulative first quarter.
  33. FY2017AdvancedAnnual report

    「R&D expenses for the consolidated fiscal year amounted to ¥2,457 million.」

    Full-year R&D expenses amounted to ¥2,457 million, up from ¥1,777 million for the cumulative quarterly period.
  34. FY2017-Q3First statedAnnual report

    「Total research and development expenses for the nine months ended were ¥1,777 million.」

    The disclosure states total research and development expenses for the nine-month period.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Hochiki's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the Earnings presentation of 2026-05-13: "Other".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.